Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 25 Issue 6, June 2007

Transgenic Caenorhabditis elegans expressing green fluorescent protein (GFP) under the control of the C12D8.1 promoter, superimposed on a post-embryonic development chronogram. Vidal and colleagues quantify the spatiotemporal activity of worm promoters using flow cytometry to record longitudinal GFP intensity profiles (p 663). Credit: Eric Smith

Editorial

  • Almost six years after the anthrax attacks, the US BioShield Program has singularly failed to add new products to the nation's stockpile.

    Editorial

    Advertisement

  • Is it a bird? Is it a plane? No, it's Boston's Supercluster!

    Editorial
Top of page ⤴

News

Top of page ⤴

News in Brief

Top of page ⤴

Profile

  • A self-made billionaire and serial entrepreneur of numerous medical device and biotech ventures, Mann has been exemplary in his philanthropy. This has not meant that his Alfred E. Mann Foundation for Biomedical Engineering (AMFBE) has been without its critics.

    • Ann Roberts Brice
    Profile
Top of page ⤴

Data Page

Top of page ⤴

News Feature

  • A small cadre of biotech companies are finding an easy entry into the consumer marketplace through the relatively unregulated field of cosmeceuticals.

    • Barbara Nasto
    News Feature
Top of page ⤴

Correspondence

Top of page ⤴

Commentary

  • A group of academics, industry executives and security experts propose an oversight framework to address concerns over the security of research involving commercial DNA synthesis.

    • Hans Bügl
    • John P Danner
    • Drew Endy
    Commentary
Top of page ⤴

Feature

  • Drugs targeting microRNAs lie some way off, but diagnostics look promising and commercial interest is growing.

    • George S Mack
    Feature
Top of page ⤴

Patents

Top of page ⤴

News & Views

Top of page ⤴

Analysis

  • Truly comprehensive proteome analysis is highly desirable in systems biology and biomarker discovery efforts. But complete proteome characterization has been hindered by the dynamic range and detection sensitivity of experimental designs, which are not adequate to the very wide range of protein abundances. Experimental designs for comprehensive analytical efforts involve separation followed by mass spectrometry–based identification of digested proteins. Because results are generally reported as a collection of identifications with no information on the fraction of the proteome that was missed, they are difficult to evaluate and potentially misleading. Here we address this problem by taking a holistic view of the experimental design and using computer simulations to estimate the success rate for any given experiment. Our approach demonstrates that simple changes in typical experimental designs can enhance the success rate of proteome analysis by five- to tenfold.

    • Jan Eriksson
    • David Fenyö
    Analysis
Top of page ⤴

Brief Communication

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Erratum

Top of page ⤴

Corrigendum

Top of page ⤴

Addendum

Top of page ⤴

Careers and Recruitment

Top of page ⤴

People

Top of page ⤴

Search

Quick links